JPRN-jRCT2080220727未知2 期
Phase II Study of S-1 plus LV (1 week on and 1 week off) as First-line Treatment for Patients with metastatic colorectal cancer.
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •20years old or more, First-line Treatment for Patients with Metastatic colorectal cancer.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Phase II study of 3-weeks cycle of S-1 as first-line for advanced pancreatic cancer (PACS-3)advanced pancreatic cancerJPRN-UMIN000011179Gifu University Hospital70
已完成
2 期
A phase II study of S-1 (14days-administrarion followed by 7days-rest ) for Metastatic Breast CancerBreast CancerJPRN-UMIN000014096Tokyo Women's Medical University25
已完成
2 期
Study of S-1 Plus LV for Untreated Metastatic Colorectal CancerColorectal CancerNCT00891332Taiho Pharmaceutical Co., Ltd.73
未知
2 期
A Randomized Phase II study of S-1 and LV versus S-1, LV and L-OHP versus S-1 and CDDP in Patients with Advanced Gastric CancerGastric CancerJPRN-jRCT2080221595Taiho Pharmaceutical Co., Ltd.144
已完成
2 期
Study of S-1 Plus LV for Advanced Gastric CancerGastric CancerNCT02090153Sun Yat-sen University39